Urotensin II receptor antagonist reduces hepatic resistance and portal pressure through enhanced eNOS-dependent HSC vasodilatation in CCl4-induced cirrhotic rats | springermedicine.com

Springer Medicine

Top

Frontiers of Medicine

Published in:

01-06-2019 | Research Article

Urotensin II receptor antagonist reduces hepatic resistance and portal pressure through enhanced eNOS-dependent HSC vasodilatation in CCl₄-induced cirrhotic rats

Authors: Ruoxi Zhang, Jing Chen, Diangang Liu, Yu Wang

Published in: Frontiers of Medicine | Issue 3/2019

Login to get access

Title: Urotensin II receptor antagonist reduces hepatic resistance and portal pressure through enhanced eNOS-dependent HSC vasodilatation in CCl4-induced cirrhotic rats
Authors: Ruoxi Zhang
Jing Chen
Diangang Liu
Yu Wang
Publication date: 01-06-2019
Publisher: Higher Education Press
Published in: Frontiers of Medicine / Issue 3/2019
Print ISSN: 2095-0217
Electronic ISSN: 2095-0225
DOI: https://doi.org/10.1007/s11684-019-0689-5

Home
Congress Coverage
Clinical Collections
- Advances in Alzheimer’s
About Springer Medicine
Key Specialties